HomeExpert Team Expert Team

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.
Filter Providers By
Expert Team
Filter Providers By
Close
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 10
  • 11
  • 12
Filter Providers By
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Zhong Guanghua
    Zhong Guanghua
    Specializes in the treatment of thoracic and head-and-neck tumors, as well as cancer pain management.Possesses extensive experience in the early diagnosis and treatment of lung cancer and the screening of pulmonary nodules;specializes in comprehensive treatment modalities for malignant tumors, including immunotherapy, targeted therapy, chemotherapy, hyperthermia, and interventional procedures.
    Profile:
    Fosun Cancer Hospital Guangzhou, Zhong Guanghua, Associate Chief Physician at the Oncology Center of Foshan Fosun Chancheng Hospital, Head of the Thoracic Oncology Sub-specialty Group, and Associate Professor at Guangzhou University of Chinese Medicine. With decades of experience in oncology diagnosis and treatment, he completed advanced training at the Cancer Center of Sun Yat-sen University. He specializes in the diagnosis and treatment of thoracic tumors, head and neck tumors, and lung cancer, and is proficient in comprehensive therapies including tumor immunotherapy and targeted therapy, chemotherapy, hyperthermia, and interventional procedures.
  • Qi Weihua
    Qi Weihua
    Proficient in conventional radiotherapy techniques such as 3D-CRT (3D Conformal Radiation Therapy), IMRT (Intensity-Modulated Radiation Therapy), and VMAT (Volumetric Modulated Arc Therapy);experienced in complex irradiation techniques including TBI, TSE, CSI, and TL; and possesses in-depth expertise in precision radiotherapy modalities like SBRT and SRS.
    Profile:
    Fosun Cancer Hospital Guangzhou, Qi Weihua, Foshan Fosun Chancheng Hospital (Director of Radiotherapy Physics Technology, Precision Oncology Diagnosis and Treatment Center; Master's degree holder). Formerly a team leader in the Radiotherapy Physics Department at PLA Hospital 307, he has many years of experience in radiotherapy physics and specializes in precision radiotherapy techniques such as IMRT and VMAT, as well as stereotactic radiotherapy (SBRT, SRS).
  • Han Liangfu
    Han Liangfu
    Specializes in the planning and implementation of multidisciplinary comprehensive treatment (MDT) for malignant tumors.Particularly expert in the comprehensive treatment and radiotherapy of breast cancer and prostate cancer; possesses extensive experience in radiotherapy scheduling and complication management for tumors such as colorectal cancer.
    Profile:
    Fosun Cancer Hospital Guangzhou, Han Liangfu, Deputy Director of the Cancer Center and Chief Expert of Radiation Oncology at Foshan Fosun Chancheng Hospital. With over 30 years of experience in the prevention and treatment of malignant tumors, he specializes in MDT (Multidisciplinary Team) comprehensive therapy, particularly in the comprehensive treatment and radiotherapy of breast cancer, prostate cancer, and colorectal cancer.
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 10
  • 11
  • 12

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.